Most state Medicaid programs do not cover weight loss medications. Federal law specifically exempts drugs used for weight loss from the requirement that Medicaid cover nearly all FDA-approved medications, making coverage entirely optional for each state. As of January 2026, only 13 state Medicaid programs cover the newer GLP-1 medications (like Wegovy and Zepbound) for obesity treatment, and that number has actually been shrinking.
Why Medicaid Can Exclude Weight Loss Drugs
Under the Medicaid Drug Rebate Program, state Medicaid agencies are required to cover almost all FDA-approved outpatient drugs. Weight loss medications are one of the few carved-out exceptions written directly into federal statute. This means each state decides independently whether to cover them, and most choose not to.
The National Association of Medicaid Directors has actively recommended that this remain optional rather than mandatory, largely because of the enormous costs involved. A single patient’s annual supply of a GLP-1 medication can run over $10,000 at list price, and states are struggling to absorb that across large Medicaid populations.
Which States Currently Cover GLP-1 Medications
The landscape is shifting quickly, and not in a favorable direction for patients. As of October 2025, 16 state Medicaid programs covered GLP-1 drugs for obesity. By January 2026, that number dropped to 13 after California, New Hampshire, Pennsylvania, and South Carolina all eliminated coverage, citing budget pressures. North Carolina also briefly dropped coverage due to a legislative budget stalemate before reinstating it in December 2025.
This volatility is important to understand. Even if your state covers these medications today, that coverage could disappear with the next budget cycle. If you’re currently on Medicaid and considering requesting a GLP-1 prescription, check your state’s current preferred drug list or call the number on the back of your Medicaid card. The situation can change within months.
Older Weight Loss Medications and Coverage
The federal exclusion applies to all drugs “used for anorexia, weight loss, or weight gain,” not just the newer, expensive ones. That language appears on nearly every state’s excluded drug list by default. This means even older, cheaper options like phentermine, diethylpropion, and phendimetrazine are typically excluded from Medicaid coverage in most states.
A review of Medicaid prescription drug policies across 34 states found that only eight had some form of possible coverage for any obesity medication. Even in those states, coverage required prior authorization and extensive medical evaluation to demonstrate treatment need. In one example, Texas listed a fat-blocking drug as “not excluded” but only covered it for high blood pressure, not weight loss.
The combination pill containing bupropion and naltrexone (sold as Contrave) and the fat-absorption blocker orlistat (Xenical) face the same state-by-state patchwork. If your state doesn’t cover weight loss drugs, the specific medication doesn’t matter: none of them will be paid for.
GLP-1 Drugs Prescribed for Diabetes, Not Weight Loss
Here’s a critical distinction. The same active ingredients in Wegovy and Zepbound are also sold under different brand names for type 2 diabetes: semaglutide as Ozempic and tirzepatide as Mounjaro. When prescribed for diabetes, these drugs fall under standard Medicaid drug coverage requirements and are much more widely available.
If you have type 2 diabetes and obesity, your doctor may be able to prescribe the diabetes-indicated version, which Medicaid is far more likely to cover. The weight loss benefits still occur. This doesn’t help people who have obesity without diabetes, but it’s worth discussing with your provider if you have both conditions.
How Managed Care Plans Affect Your Options
Most Medicaid enrollees today receive their benefits through a managed care organization (MCO) rather than traditional fee-for-service Medicaid. This adds another layer of complexity. The 13-state coverage figure applies to fee-for-service programs, but your MCO may have different rules.
MCOs are required to cover all benefits in the state plan, but they can also offer additional cost-effective services beyond what the state covers directly. In practice, this means some managed care plans in states that don’t cover weight loss drugs under fee-for-service might still offer limited coverage. It also means that even in states with coverage, your specific MCO could impose its own restrictions, preferred drug lists, or prior authorization requirements. The only reliable way to know is to contact your plan directly.
Prior Authorization Requirements
In states that do cover weight loss medications, you won’t simply get a prescription filled at the pharmacy. States universally require prior authorization, which means your doctor must submit documentation proving you meet specific criteria before the drug is approved. Common requirements include a BMI above a certain threshold (typically 30 or above, or 27 with a weight-related health condition like high blood pressure or sleep apnea), evidence that you’ve attempted diet and exercise changes, and sometimes proof that you’ve tried cheaper medications first.
This process can take days to weeks. Your doctor’s office handles most of the paperwork, but you may need to provide records of previous weight loss attempts or attend an evaluation. If you’re denied, most states have an appeals process.
Pending Federal Legislation
The Treat and Reduce Obesity Act of 2025 is currently before Congress. This bill would expand Medicare’s prescription drug benefit to cover obesity medications and broaden which providers can prescribe obesity therapy to include physician assistants and nurse practitioners. However, it primarily targets Medicare, not Medicaid, and has not yet passed. Even if it does, it would not force state Medicaid programs to cover weight loss drugs unless the underlying federal Medicaid statute is also changed.
For now, Medicaid coverage of weight loss medications remains a state-level decision, and most states have decided the cost is too high. Your most practical step is to contact your state Medicaid office or managed care plan to find out exactly what’s available where you live, since the answer depends entirely on your state and can change without much warning.